Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jul 10;79(3):672–681. doi: 10.1093/cid/ciae363

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Patient disposition in ReSTORE indicating mITT and mITT2 analysis populations. ^aSome patients met multiple reasons for exclusion and are included with each exclusion reason met. ^bPatients with either (1) a positive blood culture drawn between 12 hours before and 72 hours after randomization or (2) a positive culture from another normally sterile site sampled between 48 hours before and 72 hours after randomization and who received ≥1 dose of study drug were included in the mITT2 analysis. Figure modified from Thompson GR III et al. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet 2023; 401:49–59, with permission from Elsevier. ©2022 Elsevier Ltd. Abbreviations: COVID-19, coronavirus disease 2019; mITT, modified intention-to-treat; mITT2, modified intention-to-treat 2.